Top Sales Companies in NYC, NY (183)

Strong Revenue Growth: FY2026 results show company sales increased to roughly $8.0B, with underlying (comparable) growth strengthening after excluding the divested business. Brand-level detail indicates Coach delivered robust double-digit gains that powered the consolidated uptrend.

Profitability: Adjusted operating income and earnings per share rose markedly for FY2026 alongside operating-margin expansion. Management’s FY2027 outlook also calls for further margin improvement with low double-digit EPS growth.

Market Expansion: Growth was broad-based geographically, with notable increases in Europe and Greater China and continued strength in direct-to-consumer channels. The customer base expanded by millions in FY2026, including a meaningful Gen Z cohort.

Strong Revenue Growth: Feedback suggests ARR expanded from an estimated $170M in 2024 to $250M in 2025, indicating roughly mid-to-high-40% growth at scale. Additional narrative points to multi-year acceleration supported by rising customer counts and product breadth.

Investor Backing & Capital Strength: Feedback suggests a $166M investment led by Salesforce in September 2026, with reports of valuation rising to around $3.2B. This capital indicates continued confidence to fund expansion and strategic initiatives.

Product Line Growth: Feedback suggests expansion beyond core HR into payroll and FP&A through acquisitions like Pento (2024) and Mosaic (2025). These moves broaden cross-sell potential and support upmarket motion.

Strong Revenue Growth: Revenue momentum is characterized by an August 2025 statement that ARR was on track to quadruple that year, indicating powerful commercial acceleration. It was presented as a company-reported target rather than an audited result.

Market Expansion: Customer adoption is reflected by reported growth from more than 2,000 customers in 2023 and 5,000 paying customers in August 2025 to 30,000+ customers on the current site. Independent procurement data also indicates a rising share and a fourth-place ranking among CRM vendors.

Investor Backing & Capital Strength: Capital access is underscored by a $52 million Series B led by GV, bringing total funding to about $116 million. This provides resources for hiring, product development, and international expansion.

Strong Hiring & Retention: Hiring appears active across sales roles and geographies, signaling an investment in expansion. Available profiles also point to ongoing recruitment aligned with efforts to reach more local businesses.

Product Line Growth: The offering spans restaurant POS, payments, online and mobile ordering, kitchen displays, and automated cooking technology. This broader portfolio suggests an effort to expand revenue opportunities within hospitality.

Market Expansion: Careers listings promote independent field-sales opportunities across numerous U.S. locations alongside a New York-based role. This indicates an intended geographic reach beyond a single local team.

Strong Revenue Growth: Revenue increased from about $730 million in 2023 to $1.232 billion in 2025, and Q2 2026 revenue rose 22% year over year to $364.6 million. Management still guides to double-digit growth of roughly 19–20% for full-year 2026.

Profitability: Operating performance improved with Q2 2026 non-GAAP operating income of $61.1 million and a non-GAAP operating margin near 17%, alongside positive net income reported for 2025. Cash generation remained substantial in 2025 with strong operating cash flow and adjusted free cash flow.

Market Expansion: Larger customer segments are growing rapidly, with customers over $100,000 in ARR up 37% to 2,019 and those over $500,000 up 68% to 114 in Q2 2026. Higher-value accounts increased their share of ARR, indicating deeper enterprise penetration.

Strong Revenue Growth: Company disclosures point to multi‑year top‑line expansion, with independent credit commentary anticipating continued gains. The scale of the installed healthcare network reinforces commercial traction over time.

Market Expansion: Recent launches of a Consumer Health Network and programmatic advertising capabilities extend reach beyond traditional pharmaceutical clients and open new buying channels. These moves indicate active growth into adjacent advertiser categories within healthcare settings.

Investor Backing & Capital Strength: A definitive agreement to be acquired by a global private‑equity firm underscores institutional confidence and adds resources to accelerate network growth and product innovation. The transaction highlights access to capital to support scaling.

Strong Revenue Growth: Revenue rose 24% in 2025 to $261.1M and continued in H1 2026 with $151.4M, up 23% year over year, alongside 22% growth in bookings. These figures indicate the business is expanding commercially beyond historical momentum.

Profitability: Adjusted EBITDA increased 69% in 2025 to $40.7M with margin improving to 15.6%, and rose a further 46% in H1 2026. This points to improving operating leverage as scale increases.

Market Expansion: Active reviews grew about 20% year over year to 361M in 2025 and to 394M by H1 2026, with North America highlighted as a fast-growing region. Paying customers also increased 5% year over year in H1 2026, supporting broader commercial reach.

Strong Revenue Growth: Revenue increased 15.7% in 2025 to $6.40B, and Q2 2026 net sales rose 22.2% year over year. This acceleration indicates sustained topline momentum across recent periods.

Market Expansion: International sales grew 20.8% in 2025 and accelerated 36.6% in Q2 2026, outpacing domestic growth. This shows expanding reach beyond North America across additional countries and retailers.

Profitability: Full-year 2025 operating income rose 42.9% and net income climbed 59.9%, with adjusted EBITDA up 19.4%. This points to revenue translating into improved earnings on an annual basis.

Investor Backing & Capital Strength: Funding is highlighted by a $60 million Series D in July 2026 at a $1 billion valuation, with total reported funding of about $138.5 million. These resources are intended to support international expansion, hiring, AI development, and growth in flights, cruises, and enterprise travel.

Market Expansion: Geographic reach is broadening with growth in Canada and an official UK launch in October 2026, extending beyond the original U.S. market. The advisor community in Canada reportedly increased sharply after launch, indicating traction in new regions.

Innovation-Driven Growth: Product investment centers on AI through the acquisition of Legends and the build-out of Via to help advisors with research, itineraries, and proposals. Plans also call for expanding capabilities in categories like flights and cruises.

Strong Revenue Growth: Sustained year-over-year revenue momentum is described across 12–14 consecutive quarters, pointing to ongoing top-line expansion. Additions of 200+ net-new brands and rising spend through supply-side targeting further support commercial traction.

Market Expansion: Geographic and sectoral reach is broadening, including a Mexico launch, international CTV growth across multiple countries, and scaling buyer-development efforts. Broad ecosystem participation is also noted across more than 200,000 premium publisher domains and over 100,000 advertisers.

Product Line Growth: New offerings such as OpenXSelect and OpenXBuild, alongside continued investment in AI-driven capabilities and global supply infrastructure, reflect active expansion of the product suite. Increased usage of curated deals and supply-side targeting indicates traction for these additions.

Market Expansion: Broker and enrollment expansion is evident, with the network reported at 10,000+ brokers and approximately 250,000 enrollments in 2025, up sharply from early-2024 levels. Updates in 2026 describe adding 3,000 brokers and surpassing the prior year’s enrollment total within seven months.

Investor Backing & Capital Strength: Capital access is reinforced by a $25 million Series B in January 2024, described as a fourfold valuation step-up versus the prior round. Independent profiles also reference substantial total funding, supporting capacity to invest in product and operations.

Customer Loyalty & Retention: Client stickiness is highlighted by an average 84% retention rate after partnering. Reported partner production gains further suggest sustained engagement with Spark’s platform.

Strong Market Position & Advantage: As a distinct brand within Acosta Group since July 16, 2024, the organization sits among the two largest players, with leadership cited in the drug channel and national coverage across major retailers. The combined platform reports 60,000+ associates serving 3,000+ clients, reinforcing top-tier positioning.

Market Expansion: The acquisition expanded coverage across grocery, club, value, convenience, health/beauty, and Canada while strengthening drug-channel leadership. Access to sister agencies (e.g., Product Connections) broadens cross-sell opportunities and reach.

Innovation-Driven Growth: CROSSMARK promotes proprietary analytics/AI and omnichannel capabilities (e.g., Accelerator) supporting headquarter sales and in-store execution. This tooling is positioned as a differentiator that can drive faster client growth.

Strong Revenue Growth: Revenue is described as reaching nine‑figure ARR by late 2025 with third‑party research estimating further gains into 2026, aligning with claims of outsized year‑over‑year acceleration. Funding milestones and independent reporting are consistent with this rapid trajectory.

Investor Backing & Capital Strength: Successive valuation step‑ups from 2024–2026, including a $100M Series C at ~$3.1B and a later $5B employee tender, indicate substantial investor appetite and access to capital. Independent outlets corroborate these financings, reinforcing external confidence.

Product Line Growth: Expansion from enrichment into a broader GTM platform—adding AI agents, 100+ integrations, and the Avenue acquisition for intent signals—shows a widening product surface area. Active shipping cadence and ecosystem extensions like a ChatGPT plugin support continued product breadth.

Strong Revenue Growth: Evidence indicates Epicor surpassed $1B in annual recurring revenue and outlined plans to roughly double sales within four years, signaling momentum in subscriptions. Communications emphasize accelerating cloud migrations, which typically bolster recurring revenue mix.

Strong Market Position & Advantage: Analyst recognitions position Epicor as a Leader in Gartner’s Cloud ERP for Product‑Centric Enterprises and IDC’s SMB/midmarket ERP assessments. Independent summaries consistently frame Epicor as strong in midmarket manufacturing and distribution niches.

Investor Backing & Capital Strength: Ownership by CD&R alongside new investment from CVC is cited as support to accelerate growth and continued SaaS/AI investment. An active M&A cadence in 2024–2025 reinforces access to capital for portfolio expansion.